Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savara Inc Director's Dealing 2022

Dec 22, 2022

32709_dirs_2022-12-22_f5ff0553-7fce-4901-83ad-422383a45cdd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Savara Inc (SVRA)
CIK: 0001160308
Period of Report: 2022-12-22

Reporting Person: Pratt Raymond Dennis (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-22 Common Stock P 3500 $1.5434 Acquired 153500 Direct